2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1639303118 M.D.
Verify on CMS →

IRYNA FALKENSTEIN, M.D.

Glaucoma Specialist (Ophthalmology) Physician in OAKLAND, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 278 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
59%
generic claims · 41% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$202.16
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

IRYNA FALKENSTEIN, M.D. filed 1,319 Medicare Part D claims in 2023 as a Glaucoma Specialist (Ophthalmology) Physician in OAKLAND, California, prescribing 59% generic.

1K
Part D claims, 2023
59%
generic prescribing
$202.16
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

IRYNA FALKENSTEIN, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

1,319 Top 21% higher than 79% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). Below this entry. 1,200–1,400: 26,224 prescribers (2%). This entry sits in this band. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

IRYNA FALKENSTEIN, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about IRYNA FALKENSTEIN, M.D.?

Quality data not reported

NPI registry status

Active

Issued 05/12/2009

NPI 1639303118

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

354 US NPIs in this specialty

Medicare Part D claims

1,319 55% vs specialty avg

2023 prescription claims

Specialty avg: 2,962

Specialty distribution in California

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among California providers

California providers

Glaucoma Specialist (Ophthalmology) Physician share within California

1. Glaucoma Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Glaucoma Specialist (Ophthalmology) Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Glaucoma Specialist (Ophthalmology) Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Glaucoma Specialist (Ophthalmology) Physician ABMS/AOA estimate

Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Glaucoma Specialist (Ophthalmology) Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

IRYNA FALKENSTEIN, M.D. is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in OAKLAND, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1639303118. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

IRYNA FALKENSTEIN, M.D. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding M.D. credentials at 491 30TH ST STE 103, OAKLAND, CA, 94609, with a listed phone of (510) 763-9775. NPI 1639303118 was issued on 05/12/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FALKENSTEIN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,319 prescription claims written by this provider, covering 278 Medicare beneficiaries and totaling roughly $116K in drug spend, split 41% brand-name and 59% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

491 30TH ST STE 103
OAKLAND, CA 94609

Provider Details

NPI 1639303118
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Female
NPI Issued 05/12/2009

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for IRYNA FALKENSTEIN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$202

Largest payer

Glaukos Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to IRYNA FALKENSTEIN, M.D.. To verify IRYNA FALKENSTEIN, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

IRYNA FALKENSTEIN, M.D. — brand share 41.0%
Specialty average (est.)

41% brand-name claims vs 59% generic, on 1,319 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,319
Total Claims
$116K
Total Drug Cost
278
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,209
Total Day Supply
63,296
Brand vs Generic
41% brand / 59% generic
Brand Drug Cost
$91K
Generic Drug Cost
$25K

Patient Demographics

Average Patient Age
73.6 years
Avg HCC Risk Score
1.21
Gender Split
53% female / 47% male
Age Distribution
<65: 27, 65-74: 136, 75-84: 77, 85+: 38

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Latanoprost
386
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
247
Timolol Maleate
137
Rhopressa
Netarsudil Mesylate
93
Prednisolone Acetate
87
Brimonidine Tartrate
76
Ofloxacin
69
Dorzolamide Hcl
34
Combigan
Brimonidine Tartrate/Timolol
25
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How IRYNA FALKENSTEIN, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

354
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
2,962
Avg Claims per Provider

IRYNA FALKENSTEIN, M.D.'s 1,319 claims are below the specialty average of 2,962.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as FALKENSTEIN.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is IRYNA FALKENSTEIN, M.D.'s specialty?
IRYNA FALKENSTEIN, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in OAKLAND, California. Credentials: M.D..
How much does IRYNA FALKENSTEIN, M.D. prescribe under Medicare Part D?
In 2023, IRYNA FALKENSTEIN, M.D. wrote 1,319 Medicare Part D claims totaling $116K in drug costs for 278 beneficiaries.
Where is IRYNA FALKENSTEIN, M.D. located?
IRYNA FALKENSTEIN, M.D. is located at 491 30TH ST STE 103, OAKLAND, CA, 94609. Phone: (510) 763-9775.
What is IRYNA FALKENSTEIN, M.D.'s NPI number?
IRYNA FALKENSTEIN, M.D.'s National Provider Identifier (NPI) is 1639303118, issued on 05/12/2009.
Does IRYNA FALKENSTEIN, M.D. prescribe more brand-name or generic drugs?
IRYNA FALKENSTEIN, M.D.'s prescribing is 41% brand-name and 59% generic drugs by claim count, with $91K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 354 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 2,962 Medicare Part D claims per year.
What drugs does IRYNA FALKENSTEIN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, IRYNA FALKENSTEIN, M.D.'s most frequently prescribed drugs include Latanoprost, Dorzolamide-Timolol, Timolol Maleate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does IRYNA FALKENSTEIN, M.D. accept Medicare?
IRYNA FALKENSTEIN, M.D. appears in CMS Medicare data with 1,319 Part D claims and 278 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify IRYNA FALKENSTEIN, M.D.'s credentials?
IRYNA FALKENSTEIN, M.D.'s NPI is 1639303118 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology